Two TROP2-targeting antibody-drug conjugates, Datroway and Trodelvy, have new data suggesting they could become options for previously untreated patients with triple-negative breast cancer (TNBC).
The Ohio Prep Sports Media Association All-Southwest District high school football teams, selected by a media panel from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback